HealthTree

Your Feed

Filter by

See content from

Back to the latest

New Tool to Predict And Prevent Blood Clots in Multiple Myeloma Patients

New Tool to Predict And Prevent Blood Clots in Multiple Myeloma Patients image

First Myeloma Patient Receives New Bi-Specific Antibody (BiTE) by Teneobio and Abbvie

First Myeloma Patient Receives New Bi-Specific Antibody (BiTE) by Teneobio and Abbvie image

Thumbnail for Why should an individual get a second opinion before choosing a treatment option?

Playlist: Multiple Myeloma Basics Part 3

Why should an individual get a second opinion before choosing a treatment option?

Video details & playlist

The Mind Game of Multiple Myeloma

The Mind Game of Multiple Myeloma image

Thumbnail for What should a myeloma patient consider when choosing a treatment option?

Playlist: Multiple Myeloma Basics Part 3

What should a myeloma patient consider when choosing a treatment option?

Video details & playlist

Thumbnail for How prevalent is myeloma in the US?

Playlist: Multiple Myeloma Basics Part 3

How prevalent is myeloma in the US?

Video details & playlist

Thumbnail for How is a line of therapy defined?

Playlist: Multiple Myeloma Basics Part 3

How is a line of therapy defined?

Video details & playlist

Thumbnail for What are the risk factors for developing myeloma?

Playlist: Multiple Myeloma Basics Part 3

What are the risk factors for developing myeloma?

Video details & playlist

FDA Lifts Hold on CANOVA Venetoclax Trial in Myeloma

FDA Lifts Hold on CANOVA Venetoclax Trial in Myeloma image

Early Indications of Potential Heart Conditions Using Carfilzomib in Multiple Myeloma

Early Indications of Potential Heart Conditions Using Carfilzomib in Multiple Myeloma image

ASCO 2019: A New Cereblon Inhibitor for Multiple Myeloma

ASCO 2019: A New Cereblon Inhibitor for Multiple Myeloma image

ASCO 2019: New Updates in Smoldering Myeloma

ASCO 2019: New Updates in Smoldering Myeloma image

Patient Power: Getting Good Nutrition When You Don't Feel Like Eating

Patient Power: Getting Good Nutrition When You Don't Feel Like Eating image

Blood Cancer Patients at Greater Risk for Head and Neck Cancers

Blood Cancer Patients at Greater Risk for Head and Neck Cancers image

New Proteasome Inhibitor to Treat Multiple Myeloma

New Proteasome Inhibitor to Treat Multiple Myeloma image

Myeloma Immunotherapy in Review with Alexander Lesokhin, MD, Memorial Sloan Kettering Cancer Center

Learn more in this overview show with immunotherapy expert Dr. Alexander Lesokhin as he shares more about every type of immunotherapy being used in myeloma care

Myeloma Immunotherapy in Review with Alexander Lesokhin, MD, Memorial Sloan Kettering Cancer Center image

Listen to episode

Clinical Trial: Daratumumab, Ixazomib, and Dexamethasone With or Without Bortezomib in Patients With Newly Diagnosed Multiple Myeloma (DeRIVE)

Clinical Trial: Daratumumab, Ixazomib, and Dexamethasone With or Without Bortezomib in Patients With Newly Diagnosed Multiple Myeloma (DeRIVE) image

CLR 131 : Progress on a New Approach to Treat Relapsed/Refractory Multiple Myeloma

CLR 131 : Progress on a New Approach to Treat Relapsed/Refractory Multiple Myeloma image

Melflufen puts Melphalan in the News Again

Melflufen puts Melphalan in the News Again image

Considerations of Cost in Myeloma Care with Rafael Fonseca, MD of the Mayo Clinic, Scottsdale

Dr. Rafael Fonseca joins Myeloma Crowd Radio to share his insights about the complexity of myeloma

Considerations of Cost in Myeloma Care with Rafael Fonseca, MD of the Mayo Clinic, Scottsdale image

Listen to episode

Lenalidomide Reduces Risk of Progression in High Risk Smoldering Myeloma

St. Louis Round Table - May 18, 2019 image

St. Louis Round Table - May 18, 2019

09:00AM - 03:00PM EDT In the city timezone

St. Louis, MO - St. Louis, Missouri

Watch Recording

Off-the Shelf CAR T Cell Therapy Targeting CS1 by Cellectis with David Siegel, MD, PhD, Hackensack University

Learn more about this fascinating new approach to CAR T therapy from Dr. David Siegel, a leading myeloma researcher at Hackensack University.

Off-the Shelf CAR T Cell Therapy Targeting CS1 by Cellectis with David Siegel, MD, PhD, Hackensack University image

Listen to episode

New Discovery in the Prevention of Kidney Disease in Multiple Myeloma Patients

New Discovery in the Prevention of Kidney Disease in Multiple Myeloma Patients image

More from HealthTree